Amphastar Pharma
AMPH----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Amphastar Pharma(AMPH) predict that the Revenue is 171.17 M (--%), Miss estimate;the EBIT is 30.17 M (--%), Miss estimate;the EPS is 0.14 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.17B--
0.17B--
-0.00B--%
EBITMiss expectations
0.03B--
0.04B--
-0.01B--%
EPSMiss expectations
0.14--
0.57--
-0.4300--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf